Attributes | Values |
---|
rdf:type
| |
Description
| - V této práci jsme se pokusili zlepšit imunogenitu na GUS založené anti-E7 vakcíny zvýšením rovnovážné koncentrace tohoto fúzního proteinu. S 5' koncem GUS jsme fuzovali deleční mutanty E7GGG a kodonově optimalizovaný E7GGG, s 5' koncem GUS pak nezměněný E7GGG. Dále jsme mutovali iniciační kodon genu GUS v konstruktu E7GGG.GUS, neboť produktem tohoto fúzního genu byl samotný protein GUS. (cs)
- In this study, we attempted to improve immunogenicity of the GUS-based anti-E7 vaccines by increasing the steady-state level of fusion proteins. We fused deletion mutants of E7GGG and codon-optimized E7GGG with the 5'-terminus of GUS and unaltered E7GGG with the 3'-terminus of GUS. Furthermore, we mutated the initiation codon of the GUS gene in the E7GGG.GUS construct, as GUS alone was produced from this fusion gene.
- In this study, we attempted to improve immunogenicity of the GUS-based anti-E7 vaccines by increasing the steady-state level of fusion proteins. We fused deletion mutants of E7GGG and codon-optimized E7GGG with the 5'-terminus of GUS and unaltered E7GGG with the 3'-terminus of GUS. Furthermore, we mutated the initiation codon of the GUS gene in the E7GGG.GUS construct, as GUS alone was produced from this fusion gene. (en)
|
Title
| - Enhancement of T cell-mediated and humoral immunity of beta-glucuronidase-based DNA vaccines against HPV16 E7 oncoprotein
- Zvýšení T buňkami zprostředkované a humorální imunity proti onkoproteinu E7 z HPV DNA vakcínou založenou na beta-glucuronidáze (cs)
- Enhancement of T cell-mediated and humoral immunity of beta-glucuronidase-based DNA vaccines against HPV16 E7 oncoprotein (en)
|
skos:prefLabel
| - Enhancement of T cell-mediated and humoral immunity of beta-glucuronidase-based DNA vaccines against HPV16 E7 oncoprotein
- Zvýšení T buňkami zprostředkované a humorální imunity proti onkoproteinu E7 z HPV DNA vakcínou založenou na beta-glucuronidáze (cs)
- Enhancement of T cell-mediated and humoral immunity of beta-glucuronidase-based DNA vaccines against HPV16 E7 oncoprotein (en)
|
skos:notation
| - RIV/60077344:_____/08:00321729!RIV09-GA0-60077344
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - P(GA521/05/2092), P(GD310/05/H533), P(NR9246), Z(AV0Z50510513)
|
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/60077344:_____/08:00321729
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - immunogenicity; anti-E7 vaccines (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - International Journal of Oncology
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Vlasák, Josef
- Dušková, M.
- Ludvíková, V.
- Šmahel, M.
- Pokorná, D.
- Poláková, I.
|
http://linked.open...ain/vavai/riv/wos
| |
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |